Lifeward Q3 rev $6.1M (+39% YoY); net loss narrows to $3.1M; FY guidance $25M-$26M

Lifeward Ltd.

2024-Q3 EPS reported -$1.58 revenue$18,118,000

Revenue $6.1M, up 39% vs $4.4M in Q3 2023; ReWalk sales up 173% to $2.5M.
Net loss $3.1M ($0.35/share) vs $7.5M ($0.88) prior year; adjusted net loss $4.0M ($0.45).
Gross margin 36.2% vs 19.6% (adjusted 42.5% vs 45.1%); cash $10.7M, no debt.
FY2024 revenue guidance revised to $25M-$26M; expects highest quarterly revenue in Q4.
Announced cost savings: closing two U.S. facilities, saving ~$3M op expenses; 40 AlterG NEO units ordered.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.